Note 17 - Segments and Geographical Information - Schedule of Segment Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenue	$ 430	$ 103
Net loss	(7,732)	(8,945)
Cash	2,486	432
Total Assets	4,442	2,614
Regenerative Biotech [Member]
Revenue	0	0
Net loss	(7,247)	(8,677)
Cash	2,405	371
Total Assets	3,978	2,426
Consumer Health Products [Member]
Revenue	430	103
Net loss	(485)	(268)
Cash	81	61
Total Assets	$ 464	$ 188